Svetlana Ivanova is currently a researcher at AlixLabs (Lund, Sweden). She graduated from St. Petersburg Institute of Technology, St. Petersburg, Russia (1990) and obtained her PhD in organic chemistry at the University of Würzburg, Würzburg, Germany (1998). Dr. Ivanova is a medicinal chemist with twelve years of experience in drug discovery (respiratory, inflammation, and diabetes research areas). She has been active as a project chemistry team leader with a proven track record of delivering clinical candidates and has authored over 20 peer-reviewed journal publications and patents. Dr. Ivanova was a research scientist at Malmö University when participating in this work.